The level of Factor XII (FXII) is an important phenotype that exhibits a high genetic component and is associated with thrombotic disease. In a genome-wide linkage scan, we demonstrated that the F12 gene represents a quantitative trait locus (QTL) that influences FXII levels. The current study investigated the genetic architecture of the F12 gene to locate polymorphism(s) responsible for the variation of FXII levels. Re-sequencing of the F12 gene in 40 unrelated individuals (selected from the tails of normal distribution of FXII levels) identified 26 polymorphisms which were genotyped in 398 individuals belonging to 21 families from the GAIT Project. By a measured genotype association analysis, eight of 26 SNPs showed significant P-values less than 10 25 (after multiple test correction) with FXII levels. In addition, the Bayesian Quantitative Trait Nucleotide method, which infers those polymorphisms most likely to have a direct influence on the trait under study, provided evidence that only rs1801020 variation accounted for the variance attributed to this QTL. Moreover, we have analyzed the evolutionary processes that produced the variation in F12 gene and concluded that is evolutionarily neutral and that the T allele of the rs1801020 appeared 100 000 years ago and spread to most human populations rising to high frequencies by genetic drift. Our study provides a template for future genetic studies of human quantitative traits, as we move beyond QTL localization to the polymorphisms responsible for the variation of important biomedical phenotypes.
INTRODUCTION
Factor XII (FXII, Hageman factor) is an activator of the coagulation contact system. It is a 80 kDa protein belonging to the serine-protease family which initiates the coagulation cascade by the intrinsic pathway and also participates in the kinine activation system (1, 2) .
The gene encoding human FXII (F12) has been mapped to 5q33-qter (3, 4) . This gene is comprised 13 introns and 14 exons and the mRNA resulting from the transcription is 2 kb in size from the 8 kb of genomic DNA (3) . Although, several mutations in the F12 gene associated with FXII deficiency have been described (5 -8) , the C46T mutation that causes a moderate FXII deficiency in the homozygous state is of special interest (9) . This mutation causes a new start codon (ATG) for the transcription of the mRNA and a frameshift that produces a truncated protein. It has been documented that C46T jointly influences FXII levels and the risk of venous (10 -13) and arterial thrombosis (14 -17) .
Despite this knowledge, the biological function of FXII is poorly understood. Divergent biological functions of FXII have been described and controversial results regarding the clinical consequences of FXII activity have been reported (18, 19) . It is important to note that recent studies have shown that mice lacking FXII are nevertheless protected against arterial thrombosis and stroke (20) . Thus, the role of low or absent FXII as a potential risk factor for arterial and venous thrombosis is a matter of intense debate (21) .
As part of a family-based study, we have reported that FXII levels exhibited a high heritability (67%) and a strong genetic correlation with susceptibility to thrombotic disease (12) . Moreover, we found a strong linkage signal that clearly demonstrated that a quantitative trait locus (QTL) in the region of the F12 gene jointly influences FXII variability levels and thrombotic risk (12) . Although our results showed that the genetic variant C46T in the F12 gene was associated with the variability of FXII levels, it is unknown whether there are any other F12 polymorphisms influencing FXII levels.
It is now clear, with the advent of high throughput re-sequencing, that the next phase of genetic research must involve new methods to identify functionally polymorphisms in positional candidate genes. However, the stochastic complexity of the genotype -phenotype relationship of most common disease-related phenotypes requires that statistical inference play a prominent role in the dissection of the underlying genetic architecture. Statistical genetic methods suitable for this immense task are still in their early development. In this context, we show that in a single family-based study, it is possible to infer the allelic architecture of a human QTL using standard QTL localization methods followed by the application of two different association methods for choosing the most likely functional polymorphic variants.
In addition, we present an exhaustive study of the haplotype organization of F12 DNA sequence variation among individuals and the evolutionary processes that produced this variation. These results will play an important role in unraveling the links between genotype diversity and phenotypic variation in FXII levels. They should help also to understand the evolutionary mechanisms that generate haplotype structure in a population through the modulation of a phenotype that determines susceptibility to cardiovascular disease.
RESULTS

F12 gene analysis
We analyzed the whole F12 gene (including promoter, exons, introns and 3 0 -UTR) in 40 selected Spanish controls. This analysis represents the longest contiguous scan for sequence variation in F12 human DNA. The main objective of this strategy was to identify DNA variants in the F12 gene that might influence the variability of FXII levels and consequent thrombosis disease. From these extensive analyses, we confirmed that the F12 gene was 7476 bp long rather than the 12 000 bp. This difference in length is due to intron 1 that contains 367 bp and not the 4677 bp that has been reported (3). This result was consistent for the 40 unrelated individuals. Therefore, mutations and polymorphisms were numbered according to the transcription initiation site.
F12 DNA variants
We identified 26 allelic variants in the whole F12 gene in the 40 unrelated healthy controls. From these genetic variants, one was a variable number tandem repeat (VNTR) and 25 were single nucleotide polymorphisms (SNPs). It is worth noting that only two of the variants were located in exons and none resulted in a change at the amino acid sequence. Five of the remaining genetic variants were located in the 5 0 -UTR region or promoter and 19 in introns. Information related to all genetic variants found in the F12 gene with the allele frequencies of the rare allele of each polymorphic site, estimated from the overall GAIT sample by maximum likelihood methods, are listed in Table 1 .
In the 5 0 -UTR, we found five SNPs corresponding to a C to T transition at nucleotide 21001, an A to G transition at nucleotide 2941, a C to T transition at nucleotide 2927, an A to C transversion at nucleotide 2913 and the C46T mutation. All of them were located far from the transcription initiation site except for the widely reported mutation C46T which is located 4 bp behind the translation of exon 1. Introns were the most polymorphic regions. This is expected since introns cover more than 70% of the F12 gene. The VNTR was found also in an intron corresponding to a sequence of 6 or 7 T repeats. Among the SNPs located in exons, we found a C to T transition at exon 8, position 4989 (P218P) and a C to T transition at exon 8, position 5034 (A233A).
Within intron 2, we found a cluster of 13 SNPs in a region of 183 bp. The Seattle SNPs project found a density of one SNP per 350 bp in a population and sample size similar to ours. The binomial probability of finding 13 or more SNPs in 183 bp would be 1.4 Â 10
214
, and, considering conservatively that 10 000 such windows could be defined in the F12 gene, the probability of finding one such SNP-rich window is 1.4 Â 10 210 . This implies that the concentration of SNPs in this region significantly exceeds what can be estimated from genome-wide averages; this high SNP density may be due to an increased mutation rate in this segment.
Association analysis
All of the SNPs were in Hardy -Weinberg equilibrium (HWE) (data not shown). After the rough association analysis between FXII levels and each SNP, eight SNPs stood out with very significant P-values ( Table 1) . As we performed many tests, a Bonferroni correction for the multiple testing gives a P-value ¼ 0.002 as the critical value to accept a SNP as significant. However, as it was known that at least the C46T (rs1801020) has a functional effect on FXII levels, we hypothesized that some of the observed association could be due to Linkage disequilibrium (LD) between some SNPs and C46T. When we controlled for the effect of the rs1801020 as a covariate in the association analysis, no SNP was significant at the P-value of 0.002, only two SNPs (rs17876044 and rs17876025) were significant at a 5% type I error (Table 1 ). In addition, the signal at C46T remains significant when conditioning on the other strongly associated SNPs together (P-value ¼ 7.2 Â 10
211
).
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LD analysis
The 26 F12 markers, which were genotyped in the entire GAIT sample, were in varying degrees of disequilibrium with each other. Figure 1 shows the overall pattern of linkage disequilibrium as measured by the correlation (D 0 ) among genotypes and graphed using the computer program SOLAR. Although, on the whole, the disequilibrium is rather modest, we found complete LD between some SNPs: rs41309128 and rs41309130; rs17876018, rs17876019 and rs17876020; rs17876044, rs17876045 and rs17876046; rs4976692 and rs4976648 and also the rs17876031 and rs17876032.
On the basis of the evaluation of the eigenstructure of the correlation matrix among markers, the effective number of polymorphisms was 18. Thus, these 26 makers behave statistically like 18 independent markers. The pattern of disequilibrium among markers did not correlate with physical distance. Some markers were more than 5000 bp and were in high disequilibrium (.0.9), whereas other markers in nearby base pairs were in linkage equilibrium (0.05). Conditional upon the family information, we estimated the haplotypes of each individual using the computer program MERLIN (30) . We observed nine unique haplotypes out of the theoretical maximum of 2 26 and the sample maximum of 294 (which is equal to the number of founder genomes in the families) assuming no recombination in this small chromosomal region over the two or three generations observed. A total of 52 haplotypes had a frequency of 0.01 or greater, and it took the 13 most frequent haplotypes to capture 80% of all individuals. Thus, within this small genomic region, haplotype diversity is high and there is little evidence of useful haplotype block structure (22) . The implication of this high diversity is that there is a significant probability that the choice of a subset of markers would fail to reveal the existence of other untyped polymorphic variants. Thus, only comprehensive examination of variation in the F12 gene can guarantee that important genetic variation is not missed.
Bayesian Quantitative Trait Nucleotide analyses
We analyzed the set of 26 polymorphisms in F12 using the Bayesian Quantitative Trait Nucleotide (BQTN) method to estimate the posterior probabilities that any variant has an effect on the phenotype. Classical association analysis using the measured genotype approach indicated that eight of the polymorphisms gave evidence of marginal association.
After analysis of the marginal associations, we performed an extensive quantitative trait nucleotype (QTN) analysis. Theoretically, there are 2 26 different models of gene action that can be assessed. However, redundant sets of highly correlated polymorphism can be combined to reduce the dimensionality of the problem. We employed an automated method for forming isocorrelated redundant variant sets (IRVs). We determined that we had sufficient power to resolve the individual effects of variants that were correlated at 0.93 and used this cut-off to form such sets. Since the QTL in question was detected through a linkage model with purely additive effects, an additive model of QTN action was sufficient to account for the QTL linkage signal.
Results from the BQTN analysis showed that only one site (rs1801020), exhibited very high (.0.999) posterior probabilities of effect, whereas the rest of the genetic variants showed posterior probabilities of effect of 0. It is important to note that LD between rs1801020 (C46T) and other markers was only moderate and none of the IRVs involved C46T. In addition, Bayesian averaged estimates of the effect size of this mutation suggest that it involves large displacements in the FXII phenotype and accounts for 33.3% of the phenotypic variation in total. Thus, only one genetic variant in the F12 gene represents a major human QTL that is responsible for a large proportion of the phenotypic variance of FXII levels.
In linkage analyses conditional upon the rs1801020 variant, the LOD score on chromosome 5 was reduced from the initial LOD of 10.21 seen in the original genome screen to 0.05 (data not shown). The remaining linkage signal is not significant, implying that the variant identified in the BQTN analysis represented the major polymorphism contributing to the FXII QTL detected in our linkage screen.
rs1801020 (C46T) and FXII levels
The CC genotype in the GAIT sample showed a mean level of 128.88% in FXII in plasma, the CT genotype showed a mean value of 92.23% and the TT genotype showed a mean level of 55.58% (P , 1 Â 10
27
). This indicates that the C46T genotype was influencing FXII levels in the GAIT sample. Allele frequencies were also calculated and were 0.79 for the C allele and 0.21 for the T allele.
Evolutionary history of F12 and C46T
The basic descriptive statistics of F12 sequence variation in Spanish, European-American and African-American samples can be found in Table 2 . The levels of genetic variation were similar between Spanish and European-Americans, and both were lower than in African-Americans, as expected according to the recent African origin of humans and gene flow into African-Americans. Nucleotide diversity in F12 is similar to that found in other genes: in European-Americans, p ¼ 4.0 Â 10 24 , which ranks 81st among 322 genes in the Seattle SNPs database (as of October 2008); similarly, in African-Americans, p ¼ 5.7 Â 10
24
, which ranks 67th. This indicates that F12 has neither reduced levels of genetic diversity (as could be caused by purifying selection) or increased diversity that could be produced by balancing selection.
Neutral evolution can be specifically tested with a number of neutrality statistics (Table 2 ). Most neutrality statistics were negative in F12, due to population growth. In addition, Fu's Fs was highly significant in the Spanish sample, implying an excess of haplotypes in relation to the number of polymorphic sites. However, it may be the case that this is a false positive and that (23) , overall, the structure of genetic diversity of F12 is compatible with neutral evolution within humans. Moreover, the ratio between non-synonymous and synonymous nucleotide substitutions (K a /K s ) is 0.767 when comparing humans to chimpanzees; this implies that F12 quite freely accumulated amino acid replacements in the evolutionary branch leading to humans after the chimpanzee split. Actually, out of 12 052 genes for which K a /K s could be computed, only 1198 (10%) had larger ratios.
The evolutionary relationships of F12 haplotypes were depicted by means of a median-joining network (Fig. 2) . Three main groups of haplotypes stem directly from the root (determined by using the chimpanzee sequence); interestingly, one of them was found only in African-Americans.
The time to the most recent ancestor was estimated at 230 000 + 25 000 years ago, whereas the age of C46T was estimated at 99 800 + 18 700 years ago. Thus, C46T may have originated in Africa and spread with the 'Out of Africa' human expansion. The parallel C46T mutation has an estimated age of 2500 + 1900 years, and the two reversions of 4500 + 2500 and 7800 + 5800 years, respectively.
DISCUSSION
A major challenge for biomedicine in the genomic era is to identify the DNA polymorphisms responsible for variation in medically important complex traits (e.g. physiological risk 
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Human As an example of how a complex disease-related quantitative phenotype can be genetically dissected using a linkage/ association-based paradigm, we have analyzed quantitative levels of FXII, an important coagulation factor. We showed that in a single family-based study, it is possible to infer the allelic architecture of a human QTL using standard QTL localization methods followed by two different association methods (25) .
We would like to emphasize that only one of 26 genetic variants in the F12 gene is responsible for variability in FXII levels. This is a surprising result based on our previous knowledge of other QTLs where several genetic variants, some with opposite effects, influence the phenotype levels as is the case in the genetic dissection of the F7 gene (26) . The question is how only one genetic variation could determine the large range of FXII levels observed in the general population (normal value ranging from 80 to 120%). Some light on this question comes from our genome-wide linkage scan that involved hemostasis-related phenotypes (12), where we found two chromosomal regions that influence FXII variability levels: one on chromosome 5, where the F12 structural gene has been mapped, and another on chromosome 10 with an unknown candidate gene. This means that the effects of the chromosome 10 locus on FXII levels could vary among individuals, in different populations and/or specific environmental situations, generating the variability in the general population.
Here we see the challenge of implicating a specific gene and a polymorphism in the causation of a polygenic quantitative trait such as FXII.
It is important to note that the allelic architecture of the F12 and F7 QTLs might have broad strategic implications for the design of similar studies oriented toward dissecting genes that influence complex and quantitative traits. For the FVII:c QTL, multiple variants within the F7 gene are involved and jointly account for a large proportion of the phenotypic variation (.30%). Whereas, for the chromosome 5 FXII QTL only one single base change (C46T) accounts for all of the phenotypic variation. Thus, it is clear that some QTLs have large effects that will be localized easily using family-based linkage studies. In the case of the F7 gene, we found a single linkage signal where multiple variants influenced the phenotype to varying degrees of disequilibrium with the surrounding polymorphisms (26) . Some of these putative functional variants were not in disequilibrium with any other site, meaning that disequilibrium-based analyses using only a subset of the markers would have failed to find them. Only direct genotyping (or re-sequencing) can find these variants. This implies that partial typing approaches, even with haplotyping based on SNP tagging, will miss functional variants with measurable effects on the phenotype of interest. However, in the case of the chromosome 5, FXII QTL only typing the C46T variant was enough. That may explain why this SNP has been consistently associated with FXII levels (9, 12, 21) . However, it is difficult to know this a priori. In fact, in our study, standard association analysis using measured genotype showed multiple genetic variants in the F12 gene that influenced the phenotype. This is due to the disequilibrium structure among the markers. A marker in strong disequilibrium with a variant accounting for a large proportion of variance may give a lower P-value in the measured genotype analyses than a functional variant accounting for a lower proportion of the trait variance. Both the association analyses conditional on C46T and the BQTN analysis that formally analyzes all markers jointly supported the finding that C46T is most likely the sole functional variant in F12 in these families. Thus, our study is a good example of the necessity to combine different association tests to dissect the genetic architecture of a QTL.
Biochemical evidence has been found for a functional role of the C46CT polymorphism in the phenotypic variability of FXII levels. This transition creates a codon ATG that is located 4 bp upstream from the original translation initiation codon ATG. The putative ATG codon would result in a peptide with only two amino acids (Met-Pro) in a different frame because a TAG stop codon appears 7 bp downstream from this ATG-initiation codon (9, 21) . More importantly, this genetic variation has been reported to increases the risk of venous thrombosis (10-13), myocardial infarction (14, 15, 17) and stroke (16) . More recently, it has been also reported to be an independent risk factor for cerebral venous thrombosis (11) and venous thrombosis during the first pregnancy (10). However, the biological function of coagulation FXII is poorly understood and divergent biological functions of FXII have been described with controversial results regarding the clinical consequences of low levels of FXII activity (20, 27, 28) .
The amount of genetic variation in F12, the type of nucleotide changes accrued since the human -chimpanzee split, and various neutrality tests have shown that F12 seems to have evolved neutrally in the human lineage and in human populations. Several non-neutral scenarios could be envisaged as was posited for F7 (29) . Clearly, the C46T is a relatively ancient polymorphism, ubiquitously present in humans for at least 5000 generations and having at least two separate origins (and two reversions). The repeat mutations at this site can be explained because it lies in a CpG dinucleotide, with mutation rates one order of magnitude faster than in other dinucleotides (30) .
We have seen that F12 has evolved neutrally in humans; that a loss-of-function mutation (C46T) has appeared at least twice, at an ancient date, that is found in all continents and that its spread does not require any particular explanation beyond the demographic history of humans. In the controversy surrounding the effects of C46T, our results suggest that these may not be severe, to the point of diminishing an individual's reproductive fitness (31) .
MATERIALS AND METHODS
Subjects
The GAIT sample has been described elsewhere (12, 32) . It consists of 21 extended families (398 individuals) spread over more than two generations. To maximize the power of detecting genetic effects, families were selected for pedigree size. To be included, a family had to have at least 10 living individuals in three or more generations. Twelve families were selected through a propositus with idiopathic thrombophilia defined as multiple thrombotic events (at least one of them had to be spontaneous), a single spontaneous episode of thrombosis with a first-degree relative also affected, or onset of thrombosis before age 45. The remaining nine families were selected without regard to phenotype. Amongst the propositi, ten had early onset of thrombosis, eight experienced multiple thrombosis and only two were ascertained due to a single episode of thrombosis with an affected relative.
The propositi were considered idiopathic when all known biological causes of thrombophilia (during the recruitment period of 1995 -1997) were excluded. These thrombophilic factors were absent also in all affected relatives. The remaining nine families were selected without regard to phenotype.
All procedures were reviewed by the Institutional Review Board of the Hospital de la Santa Creu i Sant Pau (Barcelona). Adult subjects gave informed consent for themselves and for their minor children.
In addition, within the same population from which the GAIT families were recruited, a total of 40 unrelated healthy controls aged from 27 to 82 years with selected FXII plasma levels were included in the study for the purpose of detecting genetic variants. Among these individuals, 20 were selected for their high FXII levels (at least one standard deviation over the population mean after adjusting for covariates such as age and sex) and 18 for their low levels (also one standard Figure 2 . Median joining network of the putatively non-recombinant F12 haplotypes. Circle area is proportional to absolute frequency, and edge length is proportional to the number of mutations. Yellow: Spanish, blue: European-American; Red: African-American. ANC: network root determined by using the chimpanzee sequence. Black arrows: occurrences of the C46T (rs1801020) mutation; green arrows: reversions of the C46T (rs1801020) mutation.
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deviation below the population mean). The choice of this number of individuals provided a greater than 99% probability of detecting a polymorphism with a frequency of 0.05 or greater.
Blood samples and assay of plasma FXII activity
Blood samples were obtained from an antecubital vein in standard tubes anticoagulated with a 1/10 volume of 0.129 M sodium citrate. Platelet-poor plasma was obtained by centrifugation at 2 000 g for 20 min at room temperature and finally frozen and stored at 2408C. A complete thrombophilia study was performed to investigate the presence of inherited or acquired thrombophilia (12, 32 DNA isolation and F12 gene amplification DNA was isolated from peripheral blood leukocytes by the salting out procedure and purified by a standard technique (33) .
We analyzed the whole F12 gene, including the promoter, exons, 3 0 -UTR and introns. To achieve the whole sequence, we amplified four overlapping fragments by PCR and analyzed them by direct sequencing in an Applied Biosystem 3100 DNA Sequencer (GeneAmp w PCR System 9700 PE, Applied Biosystems and 3100Genetic Analyzer, Applied Biosystems) (33) . Briefly, DNA amplification was carried out from genomic DNA in a total volume of 25 ml reaction mixtures. Mixtures were made up with 100 mg of genomic DNA, 1.25 U of Herculase w Enhanced DNA Polymerase (Stratagene), 10Â Herculase w reaction buffer (Stratagene), dNTP's and oligonucleotides at a concentration of 10 mM and 5% of dimethyl sulfoxide (DMSO)(Stratagene).
PCR programs were adjusted according to the specific fragment amplification. Fragment 1 and fragment 3: started with an initial heating at 958C for 1 min, followed by 30 cycles (denaturation, annealing and extension) at 958C for 30 s, 588C for 30 s and 728C for 2 min, respectively. Fragment 2: differs from fragments 1 and 3 on the denaturation and annealing steps, which in this case was fixed at 608C for 30 s and 728C for 4 min, respectively. Fragment 4: differs from fragments 1 and 3 on the denaturation and annealing steps, this time, the denaturation step fixed at 608C for 30 s and the extension step at 728C for 2 min.
Re-sequencing the F12 gene
Re-sequencing strategy has been previously described (33) . After PCR amplification, fragments were purified by ExoSap-IT w (Amersham Biosciences), by incubating the PCR product at 378C for 15 min and 15 min at 808C, to prepare them for sequencing. The sequence reaction was performed in a 10 ml reaction volume containing 3 ml of the purified DNA, 4 ml of the DNA Sequencing Kit 'BigDye Terminator Cycle Sequencing Ready Reaction' (Applied Biosystems), 5% DMSO vol/vol and 0.32 mM of the sequencing primer. To sequence, we used the same primers used in the PCR amplification and nested primers in the longest fragments to perform gene walking. The sequencing program started with a heating step at 948C for 3 min, followed by 25 cycles consisting of 10 s at 968C, 5 s at annealing temperature (50 or 528C depending on the primer) and 4 min at 608C.
DNA sequencing of F12 was carried out in all 40 healthy controls. For each individual, the sequence of the F12 gene was analyzed. To compare and analyze all of the sequences, the Staden Package software program was used. We looked for DNA variants by comparing the entire gene among them. Each alteration in nucleotide sequence was confirmed by at least one independent PCR product. Genetic variants (mutations, polymorphisms and deletions) were numbered according to the transcription initiation site based on our sequence data from 40 unrelated controls. Allelic frequencies were calculated for all DNA variants that were identified. The newly described SNPs were submitted to dbSNP (http://www .ncbi.nlm.nih.gov/SNP/).
Genotyping of F12 gene, genotype cleaning and description
Direct sequencing, restriction fragment length polymorphism and Taqman probes specifically designed for the F12 variants were used for genotyping the genetic variants.
The genotypic data were analyzed for discrepancies (i.e. violations of Mendelian inheritance), using the PEDSYS program INFER (34) . Discrepancies were checked in the laboratory for mistyping, and markers for discrepant individuals were either corrected or excluded from the analysis. Allele frequencies were estimated from the GAIT sample using maximum likelihood techniques. HWE was tested using the x 2 method. LD between each pair of SNPs was estimated by the pairwise correlation (r) among genotypes.
Association analysis
Quantitative trait association analyses were performed using the measured genotype method (35) by testing the genotypespecific difference in the means of traits while allowing for the non-independence among family members. The three possible genotypes of a SNP were codified as 21, 0 or 1 and a model was estimated for each SNP. The significance of the SNP in a given model was calculated with the likelihood ratio test, comparing the model that includes the SNP with a nested model without it. The resultant test is distributed as a x 2 with one degree-of-freedom. The association analysis was repeated for each SNP while including C46T in the model. All the analyses were performed using SOLAR (36) .
The QTN model
The QTN model that we employed represented an extension of the classical variance component model (25) . Briefly, we modeled the phenotype, p, as a linear combination of fixed effects and random variables,
where m is the trait mean, the b l are fixed-effect regression coefficients for any measured covariates (x l ) and the q k , g and e are random effects representing other QTLs, residual genetic effects and random environmental effects, respectively. Estimation of the various fixed effects and variance components associated with the random effects were performed using standard maximum likelihood methods.
Bayesian model averaging in QTN analysis
Let Y indicate all of the data including both phenotypic and genotypic information and let M k indicate the kth model. It can be shown that p(YjM k ) is proportional to exp(2(1/2) BIC k ). Therefore, the posterior probability of the model conditional on the data is approximated by
Using this relationship in the context of QTN analysis, the posterior probability that a i = 0 is given by P K i p(M k jY), where K i denotes the set of models for which a i = 0. This is the posterior probability that the ith SNP influences the trait (assuming that all genetic variation has been assayed within the candidate locus). Using the posterior probabilities as weights, the posterior mean and variance of any parameter are easily calculated. The posterior mean a i is given by E[a i jY,
and similarly the posterior standard deviation can be calculated. The posterior mean and standard deviation of a parameter can then be used to form a statistical test that will yield the correct experiment wide P-value.
The main utility of this approach is that it directly takes into account model uncertainty and provides an estimate of our faith that a given SNP is itself functional. We have incorporated the Bayesian model averaging/model selection procedures for QTN analysis into our computer package, SOLAR (available at http://www.sfbr.org). SOLAR was modified to allow for parallel computation on a 1500 processor Unix-based computer cluster resident at the SBC Genomics Computing Center on the campus of the Southwest Foundation for Biomedical Research.
Conditional linkage/QTN analysis
To further test the validity of the positional candidate gene (i.e. F12) as identified as the observed QTL, we combined the QTN analysis with identity by descent (IBD)-based variance component linkage analysis (36) . Essentially, linkage was performed conditional on the QTNs. This allowed the assessment of whether the putative functional polymorphisms found by the QTN method could account for a given linkage signal. If the QTNs explain the original linkage signal, the LOD score in the conditional analyses will drop to zero. Interactions can be incorporated, although this will further increase the model space. However, gene action theory suggests that additive models may account for most of the variation in expression even when interactions are present (37, 38) .
Genetic population statistical analyses
Haplotypes for all independent chromosomes of the sample were constructed using family information of each founder using MRH software (Minimum Recombinant Haplotype, v.0.2) by Qian and Beckmann (39) . Additionally, the sequences for F12 in 23 African-American and 22 European-American individuals were retrieved from the Seattle SNPs project website (http://pga.gs.washington.edu) (22) . All subsequent numerical analyses were performed on the 10 121 bp region sequenced both by us and by Seattle SNPs. Nucleotide diversity (p), average number of nucleotide differences (k) and Tajima's D and other neutrality test statistics were computed using the DnaSP 4.0 package (40) ; when an outgroup was required, the chimpanzee sequence was used (41) . The significance of the neutrality tests was estimated by running 10 000 times a neutral model with a best-fit demography for Europeans and African-Americans, as implemented in the cosi software (42) . Phylogenetic relationships among haplotypes were constructed by means of a median joining network (43) , as implemented in the Network 4.1 software (www.fluxus-engineering.com); previously, haplotypes that showed clear signs of recombination defined as by Calafell et al. (44) , namely as a pattern switch at least three nucleotides long were not included in the analysis. The age of the tree as well as that of single mutation was estimated by means of the method implemented in the genetree software (45) , by using an effective population size for all humans Ne ¼ 10 000 (46) , and a generation time of 20 years.
